3,3′-Di-tert-butyl-5,5′-dimethoxy­biphenyl-2,2′-diol

por Du, Zhong-Xiang, Wang, Ling-Zhi
Publicado 2009

2-(2-Furylmethyl­ammonio)ethane­sulfonate methanol solvate

por Du, Zhong-Xiang, Wang, Ling-Zhi
Publicado 2009

Association between habenula dysfunction and motivational symptoms in unmedicated major depressive disorder

por Liu, Wen-Hua, Valton, Vincent, Wang, Ling-Zhi, Zhu, Yu-Hua, Roiser, Jonathan P.
Publicado 2017

Clinical utility of the Snaith-Hamilton-Pleasure scale in the Chinese settings

por Liu, Wen-hua, Wang, Ling-zhi, Zhu, Yu-hua, Li, Min-hui, Chan, Raymond CK
Publicado 2012

Major hepatectomy for primary hepatolithiasis: a comparative study of laparoscopic versus open treatment

por Peng, Jian-xin, Wang, Ling-zhi, Diao, Jing-fang, Tan, Zhi-jian, Zhong, Xiao-sheng, Zhen, Zhi-peng, Chen, Gui-hao, He, Jun-ming
Publicado 2018

Role of novel histone modifications in cancer

por Shanmugam, Muthu K., Arfuso, Frank, Arumugam, Surendar, Chinnathambi, Arunachalam, Jinsong, Bian, Warrier, Sudha, Wang, Ling Zhi, Kumar, Alan Prem, Ahn, Kwang Seok, Sethi, Gautam, Lakshmanan, Manikandan
Publicado 2017

Correction: Role of novel histone modifications in cancer

por Shanmugam, Muthu K., Arfuso, Frank, Arumugam, Surendar, Chinnathambi, Arunachalam, Bian, Jinsong, Warrier, Sudha, Wang, Ling Zhi, Kumar, Alan Prem, Ahn, Kwang Seok, Sethi, Gautam, Lakshmanan, Manikandan
Publicado 2018

Validation of a Rapid and Sensitive LC-MS/MS Method for Determination of Exemestane and Its Metabolites, 17β-Hydroxyexemestane and 17β-Hydroxyexemestane-17-O-β-D-Glucuronide: Appli...

por Wang, Ling-Zhi, Goh, Sok-Hwei, Wong, Andrea Li-Ann, Thuya, Win-Lwin, Lau, Jie-Ying Amelia, Wan, Seow-Ching, Lee, Soo-Chin, Ho, Paul C., Goh, Boon-Cher
Publicado 2015

Phenotyping of UGT1A1 Activity Using Raltegravir Predicts Pharmacokinetics and Toxicity of Irinotecan in FOLFIRI

por Lee, Lawrence Soon-U, Seng, Kok-Yong, Wang, Ling-Zhi, Yong, Wei-Peng, Hee, Kim-Hor, Soh, Thomas I., Wong, Andrea, Cheong, Pei F., Soong, Richie, Sapari, Nur S., Soo, Ross, Fan, Lu, Lee, Soo-Chin, Goh, Boon C.
Publicado 2016

Study protocol: phase 1 dose escalating study of Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) with oxaliplatin in peritoneal metastasis

por Kim, Guowei, Tan, Hon Lyn, Chen, Elya, Teo, Siok Chin, Jang, Clarisse Jia Min, Ho, Jingshan, Ang, Yvonne, Ngoi, Natalie Yan Li, Chee, Cheng Ean, Lieske, Bettina, Shabbir, Asim, Wang, Ling-Zhi, So, Jimmy Bok Yan, Yong, Wei Peng
Publicado 2018

Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkers

por Li, Feng, Shanmugam, Muthu K., Siveen, Kodappully Sivaraman, Wang, Fan, Ong, Tina H., Loo, Ser Yue, Swamy, Mahadeva M.M., Mandal, Somnath, Kumar, Alan Prem, Goh, Boon Cher, Kundu, Tapas, Ahn, Kwang Seok, Wang, Ling Zhi, Hui, Kam Man, Sethi, Gautam
Publicado 2015

Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients

por Wang, Ling-Zhi, Ramírez, Jacqueline, Yeo, Winnie, Chan, Mei-Yi Michelle, Thuya, Win-Lwin, Lau, Jie-Ying Amelia, Wan, Seow-Ching, Wong, Andrea Li-Ann, Zee, Ying-Kiat, Lim, Robert, Lee, Soo-Chin, Ho, Paul C., Lee, How-Sung, Chan, Anthony, Ansher, Sherry, Ratain, Mark J., Goh, Boon-Cher
Publicado 2013

Correction: Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients

por Wang, Ling-Zhi, Ramírez, Jacqueline, Yeo, Winnie, Chan, Mei-Yi Michelle, Thuya, Win-Lwin, Lau, Jie-Ying Amelia, Wan, Seow-Ching, Wong, Andrea Li-Ann, Zee, Ying-Kiat, Lim, Robert, Lee, Soo-Chin, Ho, Paul C., Lee, How-Sung, Chan, Anthony, Ansher, Sherry, Ratain, Mark J., Goh, Boon-Cher
Publicado 2014

Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer

por Tan, Tuan Zea, Miow, Qing Hao, Huang, Ruby Yun-Ju, Wong, Meng Kang, Ye, Jieru, Lau, Jieying Amelia, Wu, Meng Chu, Bin Abdul Hadi, Luqman Hakim, Soong, Richie, Choolani, Mahesh, Davidson, Ben, Nesland, Jahn M, Wang, Ling-Zhi, Matsumura, Noriomi, Mandai, Masaki, Konishi, Ikuo, Goh, Boon-Cher, Chang, Jeffrey T, Thiery, Jean Paul, Mori, Seiichi
Publicado 2013

PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein

por Thura, Min, Al-Aidaroos, Abdul Qader, Gupta, Abhishek, Chee, Cheng Ean, Lee, Soo Chin, Hui, Kam Man, Li, Jie, Guan, Yeoh Khay, Yong, Wei Peng, So, Jimmy, Chng, Wee Joo, Ng, Chin Hin, Zhou, Jianbiao, Wang, Ling Zhi, Yuen, John Shyi Peng, Ho, Henry Sun Sien, Yi, Sim Mei, Chiong, Edmund, Choo, Su Pin, Ngeow, Joanne, Ng, Matthew Chau Hsien, Chua, Clarinda, Yeo, Eugene Shen Ann, Tan, Iain Bee Huat, Sng, Joel Xuan En, Tan, Nicholas Yan Zhi, Thiery, Jean Paul, Goh, Boon Cher, Zeng, Qi
Publicado 2019

Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein

por Thura, Min, Al-Aidaroos, Abdul Qader, Gupta, Abhishek, Chee, Cheng Ean, Lee, Soo Chin, Hui, Kam Man, Li, Jie, Guan, Yeoh Khay, Yong, Wei Peng, So, Jimmy, Chng, Wee Joo, Ng, Chin Hin, Zhou, Jianbiao, Wang, Ling Zhi, Yuen, John Shyi Peng, Ho, Henry Sun Sien, Yi, Sim Mei, Chiong, Edmund, Choo, Su Pin, Ngeow, Joanne, Ng, Matthew Chau Hsien, Chua, Clarinda, Yeo, Eugene Shen Ann, Tan, Iain Bee Huat, Sng, Joel Xuan En, Tan, Nicholas Yan Zhi, Thiery, Jean Paul, Goh, Boon Cher, Zeng, Qi
Publicado 2021